Skip to main content

Table 1 Distribution of rs1801725 and rs1801726 CaSR alleles in control subjects versus breast cancer cases

From: Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients

SNP ID

Genotype

Mutant

CaSR

Controls

n = 384

Breast cancer

cases n = 199

All samples

n = 583

   

n

%

n

%

n

%

RS1801725

G/G

A986A

304

79%

154

77%

458

79%

G/T

A986S

74

19%

41

21%

115

20%

T/T

S986S

6

2%

4

2%

10

2%

RS1801726

C/C

Q1011Q

328

85%

178

89%

506

87%

C/G

Q1011E

50

13%

19

10%

69

12%

G/G

E1011E

6

2%

2

1%

8

1%

   

Blacks

N = 171

Whites

N = 412

All samples

N = 583

RS1801725

G/G

A986A

154

90%

304

74%

458

79%

G/T

A986S

16

9%

99

24%

115

20%

T/T

S986S

1

1%

9

2%

10

2%

RS1801726

C/C

Q1011Q

121

71%

385

93%

506

87%

C/G

Q1011E

42

24%

27

7%

69

12%

G/G

E1011E

8

5%

0

0%

8

1%